PainQx
PrivateLast Round
Series A
Aug 28, 2021
Total Funding Raised
$3.67M
Company Overview
PainQx operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Grant round in June 2021.
PainQx is a digital health company that has developed an AI-powered platform for the objective, quantitative assessment of chronic pain using EEG data.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PainQx Comparables
Compare PainQx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioTraceIT | 80% | |
| AlgometRx, Inc. | 79% | |
| Cumulus Neuroscience | 79% |
For institutional investors. Book with your work email.
PainQx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 28, 2021 | ||||
| Grant | Jun 9, 2021 | ||||
| Grant | Sep 24, 2019 | ||||
| Seed | Aug 28, 2017 |
For institutional investors. Book with your work email.
PainQx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| Defense Health Agency | Grant |
| Arizona Tech Investors | Seed |
| Accelerate Long Island | Seed |
| NYU Innovation Venture Fund | Seed |
| MABA | Seed |
| Italian Angels for Growth | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2021
Completed a Series A funding round.
- Jun 9, 2021
$1.5M grant awarded by the Defense Health Agency.
For institutional investors. Book with your work email.
PainQx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PainQx's valuation, stock price, and market status.
Is PainQx a public or private company?
PainQx is a private company.
What is the current stock price of PainQx?
PainQx is a private company, so its shares have no public market price. Caplight tracks PainQx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PainQx worth (valuation)?
Valuation information for PainQx is not publicly available.
Can I buy PainQx stock?
PainQx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PainQx's last funding round?
PainQx's most recent funding round was Series A on August 28, 2021.
Who are the main investors in PainQx?
Key investors in PainQx include National Institute on Drug Abuse, Defense Health Agency, Arizona Tech Investors, Accelerate Long Island, NYU Innovation Venture Fund.
Will PainQx IPO soon?
No public IPO plans have been announced for PainQx.
How can I track PainQx secondary market activity?
Caplight tracks bids, offers, and trades in PainQx's shares on secondary markets.